Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion type Assertion NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_head.
- NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion description "[Because FXR1 is overexpressed and associated with poor clinical outcomes in multiple cancers, these results have implications for other solid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_provenance.
- NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion evidence source_evidence_literature NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_provenance.
- NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion SIO_000772 25733852 NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_provenance.
- NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion wasDerivedFrom befree-2016 NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_provenance.
- NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_assertion wasGeneratedBy ECO_0000203 NP1267669.RA-UKLk1AQfg3WiOXuFoNcbq-s_z3197aK-86dBMhBYGw130_provenance.